en
E-mail us
cn
API Stability and Solubility Studies
De-Risking Your API for Real-World Conditions

Comprehensive stability and solubility studies are essential for understanding how an API behaves under real-world pharmaceutical development conditions. At Crystal Pharmatech, we evaluate both chemical and solid-state stability as well as solution behavior to identify risks such as form changes, amorphous crystallization, salt deliquescence, and degradation pathways.

By systematically probing these vulnerabilities, our studies help define the conditions that may impact formulation, manufacturing, and long-term product stability.

Comprehensive API Stability Testing

Our stability studies evaluate the chemical and physical resilience of APIs under conditions relevant to pharmaceutical development and ICH stability guidelines.

Forced Degradation Studies

Stress testing under acid, base, hydrolysis, oxidation, elevated temperature, and light exposure to identify degradation pathways.

Solid-State Stability

Assessment of polymorphic stability and physical form integrity across temperature and humidity conditions.

Chemical Stability

Targeted stability testing across controlled temperature and humidity profiles to determine degradation susceptibility.

Advanced API Solubility Profiling

Reliable solubility data are essential for predicting dose feasibility, supporting DCS classification, and guiding early formulation strategy. Our solubility studies evaluate both equilibrium and dynamic behaviors across physiologically relevant environments.

Kinetic and Thermodynamic Solubility

Determination of both transient and equilibrium solubility behavior.

pH-Dependent Solubility Profiling

Evaluation of solubility across physiological pH ranges to support formulation and absorption predictions.

Biorelevant Media Testing

Solubility measurements in simulated intestinal and gastric fluids including FaSSGF, FaSSIF, and FeSSIF.

Achieve Your Success with Our Expertise

Have a question or need support with your project? Please complete the form, and our team will get back to you shortly.




Our capabilities span three specialized platforms:

  • Small Molecule

  • Crystal Bio Solutions

  • Crystal NAX


By providing your e-mail address, you agree to receive an e-mail response from Crystal Pharmatech to your inquiry. The information you submit will be governed by our Privacy Policy.

Related Resources
Small Molecule Crystal Bio Solutions
Biologics Characterization and CMC Analytics Bioanalytical and Biomarker Services Quantitative Clinical Pharmacology (QCP)
Crystal NAX
DNA Synthesis RNA Synthesis LNP Formulation Services Analytical & Characterization Services Early-Phase Manufacturing Catalogue Products
Contact Us
bd_global@crystalpharmatech.com (925) 558-5040
U.S
NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512

2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512

CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566
Canada
6800 Kitimat Rd, Unit 1, Mississauga, Ontario, Canada L5N 5M1
China
No. 288, Jiangyun Road, Suzhou Industrial Park, Suzhou, China 215123

Floor 1, Bldg. 3, 68 Chunpu Road, Suzhou Industrial Park, Suzhou, China 215123
Subscribe to be the first to get the updates!

Subscribe to be the first to get the updates!

NJ Sites: Suite 500-B, 3000 Eastpark Blvd, Cranbury, New Jersey, USA 08512

2005 Eastpark Blvd, Cranbury, New Jersey, USA 08512

CA Site: 7133 Koll Center Parkway, Suite 200, Pleasanton, California, USA 94566
bd_global@crystalpharmatech.com (925) 558-5040